← Eichor
Study identifier: NCT06607406 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery

Condition: Head and Neck Cancer · Head and Neck Squamous Cell Carcinoma HNSCC  ·  Sponsor: Wake Forest University Health Sciences

PhaseNA
Planned participants75
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to determine whether accelerated radiotherapy (involving 6 treatments per week) is better than standard radiotherapy (involving 5 treatments per week) at treating cancer of the head and neck when initiated more than 6 weeks after surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Ryan Hughes, MD  ·  336-713-6575  ·  ryhughes@wakehealth.edu

Always discuss trial participation with your own doctor first.

Locations (3)

Levine Cancer InstituteCharlotte, North Carolina, United StatesRecruiting
Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, North Carolina, United StatesRecruiting
Advocate Aurora Radiation OncologyMilwaukee, Wisconsin, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06607406